Star Combo Pharma Ltd. ( (AU:S66) ) has issued an update.
Star Combo Pharma Ltd announced the settlement of insurance claims related to damages from two fires at its factory in 2022, resulting in a $5 million payment. This settlement is expected to provide financial relief and stability, potentially enhancing the company’s operational capabilities and market positioning.
More about Star Combo Pharma Ltd.
Star Combo Pharma Ltd is a Sydney-based contract manufacturer specializing in vitamins, health, and beauty products. The company offers a range of own brands and distribution capabilities, focusing on natural ingredients and adhering to high manufacturing standards set by the Therapeutic Goods Administration. Star Combo supplies products to the Australian pharmacy network, including 450 Terry White Chemmart stores, and has wholesale customers in Australia, Vietnam, and China. Established in 2004, the company aims to be a leading manufacturer of premium vitamins and dietary supplements in Australia.
YTD Price Performance: -17.86%
Average Trading Volume: 20,629
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$15.53M
See more insights into S66 stock on TipRanks’ Stock Analysis page.